Inventor
KOTHS KIRSTON
US14 patents
⚠️ This page may combine multiple inventors who share the name “KOTHS KIRSTON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CHIRON CORP
8 patentsUS6184354B1Feb 6, 2001
Soluble extracellular domain of human M-CSF receptor
CHIRON CORP50 citations96
US5866114AFeb 2, 1999
Crystallization of M-CSFα
CHIRON CORP52 citations92
US6322779B1Nov 27, 2001
Recombinant human CSF-1 dimer and compositions thereof
CHIRON CORP18 citations91
US5614185AMar 25, 1997
Compositions containing reduced, microbially produced interleukin-2 (IL-2)
CHIRON CORP24 citations91
US5861150AJan 19, 1999
Recombinant human CSF-1 dimer and compositions thereof
CHIRON CORP5 citations72
US6025146AFeb 15, 2000
Identification of M-CSF agonists and antagonists
CHIRON CORP13 citations70
US5830684ANov 3, 1998
Native type II GAP, methods for purifying various GAPs and uses of GAPs to diagnose cancer
CHIRON CORP2 citations61
US5651963AJul 29, 1997
Heterodimers forms of CSF-1 and pharmaceutical compositions thereof
CHIRON CORP4 citations61
NOVARTIS VACCINES & DIAGNOSTICS INC
3 patentsUS9926371B2Mar 27, 2018
M-CSF specific monoclonal antibody and uses thereof
NOVARTIS VACCINES & DIAGNOSTICS INC7 citations81
US11034759B2Jun 15, 2021
Humanized M-CSF specific monoclonal antibodies, kits, and uses thereof
NOVARTIS VACCINES & DIAGNOSTICS INC0 citations60
US9522186B2Dec 20, 2016
M-CSF specific monoclonal antibody and uses therof
NOVARTIS VACCINES & DIAGNOSTICS INC1 citations60